News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioLight Life Sciences Investments Ltd and Aerie Pharmaceuticals, Inc. Affiliates Announce a Collaboration for Continued Development of a Controlled-Release Ocular Implant for the Delivery of Ophthalmic Medications



11/7/2012 9:39:01 AM

TEL AVIV, Israel & BEDMINSTER, N.J., Nov. 6, 2012 (GLOBE NEWSWIRE) -- ViSci Ltd., a wholly owned subsidiary of BioLight Ltd. (TASE:BOLT) entered into an option agreement with Novaer LLC, an affiliate of Aerie Pharmaceuticals Inc., to license the Eye-DTM technology for further development of a sub-conjunctival drug implant for the controlled release of ophthalmic medications.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES